the significant cost of guideline implementation have created a dilemma between potentially improved postoperative adverse events and increased health-care resource utilization. In practice, fewer than 20% of patients with a diagnosis of OSA receive CPAP therapy, are observed in advanced care settings, or both. 18 This review examines the evidence regarding the use of CPAP in the preoperative and postoperative periods in surgical patients with diagnosed and undiagnosed OSA.
Surgical Patients With OSA and Perioperative Complications
A close relationship exists among OSA, sleep, and anesthesia. Upper airway behavior during sleep serves to some extent as a surrogate of airway behavior during anesthesia and recovery from anesthesia. Likewise, upper airway abnormalities observed by anesthesiologists during the perioperative period is likely to predict upper airway behavior during sleep. 19 A patient with an upper airway that is prone to collapse may also be at increased risk of compromised arousal mechanism in the postoperative period. Several large database studies and two meta-analysis have shown that patients with OSA have increased risk of postoperative complications. 3, 4, [20] [21] [22] [23] [24] [25] Two recent metaanalysis of 13 and 17 studies indicate that, compared with patients with OSA, patients with OSA have a higher incidence of respiratory complications, postoperative cardiac events, and increased ICU transfer. 24, 25 In line with the meta-analysis, five recent studies using data from large national and international databases including millions of patients demonstrated a significantly increased risk of atrial fibrillation, respiratory failure, aspiration pneumonia, ARDS, increased emergent postoperative endotracheal intubation, and need for postoperative ventilation among patients with a diagnosis of OSA vs control subjects. 3, 4, [20] [21] [22] 26 D'Apuzzo et al 20 demonstrated that there is increased mortality in OSA vs patients without OSA undergoing revision joint arthroplasty (OR, 1.9; P ¼ .002). That this study included patients undergoing revision arthroplasty may suggest a higher burden of comorbidities. Paradoxically, the increased risk of cardiopulmonary complications did not translate into increased risk of in-hospital mortality in two studies. 4, 20 There may be several reasons behind the reduction in in-hospital mortality: (1) patients with OSA may have received more vigilant care; (2) patients with OSA may have exhibited signs of deterioration earlier in their hospital course; (3) the reason behind respiratory failure in patients with OSA may have been easier to treat (eg, respiratory failure from upper airway compromise vs aspiration pneumonia or ARDS); or (4) in the control group, patients may have undiagnosed OSA with increased risk of mortality and morbidity. Indeed, in two studies of postsurgical patients, 4, 20 those with an OSA diagnosis who developed respiratory failure were intubated earlier and received mechanical ventilation for a shorter period, suggesting that the cause of respiratory failure was rapidly reversible, perhaps related to upper airway complications resulting from sedatives and opioid analgesics.
In the general population, a significant proportion of patients with moderate to severe OSA remains undiagnosed. 27 This corollary may also apply to the surgical patients in the perioperative period. In a retrospective nested cohort study, preoperative screening followed by PSG was performed to identify patients with OSA, and the results were blinded to the perioperative care team. Both anesthesiologists and surgeons failed to identify a majority of the newly diagnosed patients with moderate to severe OSA. 28 Patients with undiagnosed OSA presenting for surgery may have further increase in cardiopulmonary complications. [29] [30] [31] Postoperative Use of CPAP in Surgical Patients Without OSA
The efficacy of CPAP in patients without a diagnosis of OSA has been well-established by a recent meta-analysis of nine randomized controlled trials (RCTs) in patients undergoing abdominal surgery. 32 These studies have
shown that perioperative use of CPAP leads to a reduction in the rate of postoperative pulmonary complications. In 200 patients who developed hypoxemia immediately after undergoing major abdominal surgery, the use of postoperative CPAP at 7.5 cm H 2 O plus supplemental oxygen using a helmet interface led to a reduction in the incidence of endotracheal intubation, pneumonia, infection, and sepsis when compared with supplemental oxygen alone. 33 Significant reduction in the rate of pulmonary complications with the prophylactic use of nasal CPAP was also demonstrated in patients undergoing thoracoabdominal aortic surgery and cardiac surgery. The number of surgical cases performed globally is increasing, and an estimated 250 million major surgeries are being performed each year. 36 With the global rise of obesity, the prevalence of OSA will likely continue to rise. 1, 2 Perioperative care of patients with OSA will be an increasing challenge. The concept of perioperative surgical home, encompassing optimization of surgical patient's health status from preoperative period to postoperative discharge care for conditions, such as coronary heart disease, congestive heart failure, COPD, or diabetes, has become the new reality. 37 The same concept applies to patients with suspected or diagnosed OSA presenting for surgery, where the association of OSA with postoperative complications has been a wakeup call for action. 38 Anesthesiologists are in an ideal position to identify patients with SDB, optimize their perioperative management, and contribute to their continuum of care. Because CPAP therapy has longterm health benefits for patients with OSA, preoperative clinics may provide an opportunity for identification of patients with undiagnosed OSA and initiation of treatment. In a recent study, surgical patients were screened for OSA in a preoperative clinic and were offered CPAP therapy. Those who were CPAP-adherent had better sleep quality, less daytime sleepiness, and reduction of medication usage for associated medical diseases. 39 , two patients with OSA without CPAP suffered postoperative adverse events and one patient died, whereas 14 patients with OSA treated with CPAP had uneventful postoperative courses. In a retrospective case-control study, patients with OSA without CPAP had more postoperative complications than patients with OSA treated with CPAP (44% vs 27%, P ¼ .02). Unplanned ICU transfer was also significantly higher in patients with OSA without CPAP treatment and length of stay was 1 day longer. 41 In a retrospective cohort match study, Liao et al 42 47 There was also a trend toward significance for reduction in the length of hospital stay of 0.4 days favoring the CPAP group (CPAP vs no-CPAP: 4.0 AE 4 vs 4.4 AE 8 days, P ¼ .05). 47 Even though five studies supported the use of CPAP in the perioperative period, they were not included in the meta-analysis by Nagappa et al 47 ( Table 2) , because of a lack of data in either the study group and/or control group. In a retrospective chart review by Meng et al, 48 patients who did not use CPAP had a significantly higher incidence of postoperative hypertension (CPAP vs no-CPAP group: 18% vs 29%; P ¼ .013) and oxygen desaturations (CPAP vs no-CPAP group: 5% vs 43%; P ¼ .012). Also, the length of postanesthesia care unit (PACU) stay was longer in the no-CPAP group when compared with the CPAP group (211 AE 82 min vs 159 AE 78 min, P ¼ .029). Neligan et al 49 conducted an RCT on morbidly obese patients with OSA undergoing laparoscopic bariatric surgery. The administration of likely because of inadequate statistical power. [53] [54] [55] Given the association between the severity of OSA and postoperative outcomes, efforts targeting patients with moderate-to-severe undiagnosed OSA in preoperative screening may be more clinically relevant. [56] [57] [58] [59] [60] [61] In another supporting study, Abdelsattar [65] [66] [67] [68] Empiric APAP therapy has been studied in three studies 44, 45, 69 and successfully applied in the perioperative care of patients at risk for OSA ( Although APAP improved obstructive apneas and hypopneas, a full resolution of SDB did not occur in these studies. The preoperative AHI was reduced by an average of 25 events/h postoperatively. Some residual SDB persisted, with a mean AHI 12 AE 16 events/h in the recent meta-analysis. 47 Brar et al 67 found that 18% of surgical patients spent at least 30 min with SpO 2 < 90% the night following surgery despite the use of their prescribed PAP therapy. 67 The severity of baseline OSA, pre-CPAP SpO 2, net fluid balance, total IV opioid dose, and central apneas may be the contributing factors to hypoxemia. 12,13,60,65,67 As such, it has been suggested that postoperative oximetry monitoring may be indicated in PAP-treated patients with OSA. 67 In the meta-analysis of perioperative CPAP use, the length of stay was 0.4 days shorter in the CPAP group vs the no-CPAP group. 47 On the contrary, O'Gorman et al 45 showed that there was no benefit for APAP applied postoperatively to patients who were identified as being at high risk of OSA by screening vs patients who receive usual care. The negative results of the study may be due to a type 2 error, with an inadequate sample size and inadequate oxygen supplementation resulting from diluting effects of high flow induced by APAP. 70 
Barriers to Preoperative Diagnosis of OSA and Perioperative CPAP Therapy in Surgical Patients
There are several barriers to effective diagnosis and treatment of OSA in the perioperative setting. In both clinical and research settings, a significant proportion of journal.publications.chestnet.org patients who may have suspected OSA refuse to undergo additional testing for establishing an OSA diagnosis.
44,69
Guralnick et al 69 speculated that the inconvenience of an overnight in-laboratory PSG or even out-of-center sleep testing, the short time available between evaluation by the anesthesia team and the actual date of surgery, cost, underappreciation of the implications of undiagnosed and untreated OSA by patients and clinicians, lack of understanding of the consequences of untreated OSA, and unwillingness to use CPAP may have all contributed to the failure of surgical patients to accept and adhere to perioperative diagnosis and treatment of OSA. These reasons may explain why only approximately 45% of patients with newly diagnosed OSA were adherent to APAP therapy in the perioperative period. 44, 69 Other factors that have been associated with reduced APAP adherence in the perioperative period include African American race, male gender, and depressive symptomatology. 69 In two studies, the optimal level of APAP was 9 AE 2 cm H 2 O in surgical patients with newly diagnosed OSA. 44, 69 This information could be used empirically to prescribe the minimum and maximum pressure settings on APAP devices if clinicians need to prescribe APAP in the postoperative period for patients suspected of having OSA but who have not undergone formal sleep testing or PAP titration.
Postoperative CPAP utilization has been reported to be suboptimal even in patients with an established diagnosis of OSA. Gupta et al 41 found that only onethird of patients who were on home CPAP therapy used their CPAP during the postoperative stay in the hospital. Liao et al 42 found that only 63% of patients on home CPAP therapy received postoperative CPAP. Intensive education of health-care professionals and patients is needed to ensure that patients are instructed to bring their CPAP device to the hospital and to continue to use CPAP therapy during the vulnerable postoperative period. In lieu of patients bringing their own CPAP units, effective APAP therapy can be provided to the patient by using hospital APAP or CPAP devices.
Who Are the Surgical Patients With OSA at Increased Risk?
It is not known which subgroups of patients with SDB are more likely to benefit from PAP therapy. Patients with obesity hypoventilation syndrome, overlap syndrome, patients with severe OSA (AHI > 30), and patients with a high arousal threshold with recurrent severe hypoxemia may possibly benefit from preoperative PAP therapy. Patients with OSA and unrecognized obesity hypoventilation syndrome or overlap syndrome (COPD and OSA) had higher risks of postoperative respiratory failure, heart failure, prolonged See Table 1 legend for expansion of abbreviations.
intubation, and longer ICU and hospital length of stay than patients with nonhypercapnic OSA. 71 Therefore, hypercapnia can be an important risk modifier. Although many patients normally do not have measurements of arterial blood gases, high serum bicarbonate in venous blood can serve as a surrogate for hypercapnia and may help to identify patients with obesity hypoventilation syndrome. [72] [73] [74] Identifying this patient population is critical because CPAP use may not be sufficient and other advanced modes of PAP therapy such as bilevel PAP with or without a backup rate may have to be applied.
Recently, it was shown that 26% of patients without OSA (preoperative AHI < 5) developed moderate-tosevere SDB (AHI > 15) in the first 1 to 3 days after surgery. 75 In these patients, preoperative respiratory effort-related arousals may have converted to apneas or hypopneas in the postoperative period, likely because of increased upper airway collapsibility. The reasons behind increased upper airway collapsibility may be related to rostral fluid shifts and/or respiratory depression induced by opioids and sedatives. 12, 13, 65, 76, 77 In this study, preoperative respiratory disturbance index, rather than the AHI, and age were significant predictors of postoperative moderate-to-severe SDB. 75 As a result, it was suggested that in surgical patients, respiratory disturbance index may be more useful than AHI in diagnosing OSA.
Mutter et al 30 identified patients with more severe OSA (AHI > 30) to be at higher risk of adverse postoperative cardiopulmonary events, but it is not known whether AHI by itself is the best metric of OSA severity to risk stratify perioperative patients with OSA. Other metrics of OSA severity in the surgical patients such as mean preoperative overnight SpO 2, oxygen desaturation index, and total sleep time below 90% SpO 2 may be useful as well. Chung et al 60 found that patients with mean preoperative overnight SpO 2 < 93%, oxygen desaturation index > 29 events/h or more than 7% total sleep time < 90% SpO 2 were at higher risk of postoperative adverse events.
Another less-recognized cause of sudden death in patients with OSA is arousal failure. It has been suggested that an obstructive sleep apneic event may not spontaneously terminate because of an ineffective arousal mechanism related to impaired chemosensitivity and/or opioid-induced respiratory depression, leading to profound cerebral hypoxemia and ultimately death. 76, 77 Further research is necessary to determine the various phenotypes of OSA and which metrics of SDB severity are likely to predict postoperative adverse events. Measures of hypoxemic exposure as well as hypercapnia need to be taken into account when risk-stratifying patients with SDB. Given the preponderance of data on long-term benefits and improved prognosis of patients with OSA with CPAP treatment, screening surgical patients for OSA and initiating PAP therapy in the perioperative period may be medically appropriate. 79, 80 With accumulating evidence from studies, 3, 12, 13, 21, 22, 24, 25, 30, 31, 81, 82 it may be ethically difficult to perform RCTs. Moreover, given the overall low rates of postoperative complications, another challenge is designing RCTs that are adequately powered to detect these clinically meaningful outcomes. 18 With the increased awareness of postoperative complications associated with OSA, researchers may face increasing rates of unwillingness on the part of patients and their physicians to participate in RCTs. 56 The field of perioperative medicine is not unused to these challenges; a similar dilemma regarding perioperative monitoring with pulse oximetry occurred in the 1980s. Because of the overall low rates of adverse events, RCTs have failed to show differences in postoperative complications, length of stay, or death between those monitored by oximetry and control subjects. 83 In spite of that, anesthesiologists have universally adopted monitoring patients with pulse oximetry in operating rooms and PACUs. Subsequently, patients have benefitted from increased safety with anesthesia despite the absence of positive findings of benefits from RCTs on oximetry monitoring. Another example is malignant hyperthermia (MH), a serious complication. 84 During the past few decades, surgical patients are screened for a journal.publications.chestnet.org personal or family history of MH and an anesthesia protocol is followed. 84 What are the cost implication, costeffectiveness, and cost-benefit considerations of preoperative diagnosis of OSA and implementation of PAP therapy? Without a doubt, more research is needed to provide answers to some of these clinically relevant questions. In the meantime, clinical acumen and a commonsense approach is needed to identify surgical patients with undiagnosed OSA who may be at risk for postoperative adverse events who could benefit from CPAP therapy and postoperative monitoring.
In conclusion, diagnosing OSA and using perioperative CPAP therapy may be effective interventions to reduce the incidence of postoperative adverse outcomes in patients with OSA undergoing surgery. Further research in this area is needed to determine whether this strategy has a positive effect on hospital resource utilization and reduction in cost of the health-care system.
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